BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Watanabe S, Iga J, Ishii K, Numata S, Shimodera S, Fujita H, Ohmori T. Biological tests for major depressive disorder that involve leukocyte gene expression assays. Journal of Psychiatric Research 2015;66-67:1-6. [DOI: 10.1016/j.jpsychires.2015.03.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ozaki T, Yoshino Y, Tachibana A, Shimizu H, Mori T, Nakayama T, Mawatari K, Numata S, Iga JI, Takahashi A, Ohmori T, Ueno SI. Metabolomic alterations in the blood plasma of older adults with mild cognitive impairment and Alzheimer's disease (from the Nakayama Study). Sci Rep 2022;12:15205. [PMID: 36075959 DOI: 10.1038/s41598-022-19670-y] [Reference Citation Analysis]
2 Yu S, Li W, Tang L, Fan X, Yao S, Zhang X, Bi Z, Cheng H. Depression in breast cancer patients: Immunopathogenesis and immunotherapy. Cancer Letters 2022;536:215648. [DOI: 10.1016/j.canlet.2022.215648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ueno M, Yoshino Y, Mori H, Funahashi Y, Kumon H, Ochi S, Ozaki T, Tachibana A, Yoshida T, Shimizu H, Mori T, Iga J, Ueno S. Association Study and Meta-Analysis of Polymorphisms and Blood mRNA Expression of the ALDH2 Gene in Patients with Alzheimer’s Disease. JAD 2022. [DOI: 10.3233/jad-215627] [Reference Citation Analysis]
4 Becerril-villanueva E, Olvera-alvarez MI, Alvarez-herrera S, Maldonado-garcía JL, López-torres A, Ramírez-marroquín OA, González-ruiz O, Nogueira-fernández JM, Mendoza-contreras JM, Sánchez-garcía HO, José-alfallo JA, Valencia Baños A, Torres-serrano AB, Jiménez-genchi J, Mendieta-cabrera D, Pérez-sánchez G, Pavón L. Screening of SERT and p11 mRNA Levels in Airline Pilots: A Translational Approach. Front Psychiatry 2022;13:859768. [DOI: 10.3389/fpsyt.2022.859768] [Reference Citation Analysis]
5 Kumon H, Yoshino Y, Funahashi Y, Mori H, Ueno M, Ozaki Y, Yamazaki K, Ochi S, Mori T, Iga JI, Nagai M, Nomoto M, Ueno SI. PICALM mRNA Expression in the Blood of Patients with Neurodegenerative Diseases and Geriatric Depression. J Alzheimers Dis 2021;79:1055-62. [PMID: 33386803 DOI: 10.3233/JAD-201046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
6 Mori H, Funahashi Y, Yoshino Y, Kumon H, Ozaki Y, Yamazaki K, Ochi S, Tachibana A, Yoshida T, Shimizu H, Mori T, Iga JI, Ueno SI. Blood CDKN2A Gene Expression in Aging and Neurodegenerative Diseases. J Alzheimers Dis 2021;82:1737-44. [PMID: 34219731 DOI: 10.3233/JAD-210483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Martín-Sánchez A, Piñero J, Nonell L, Arnal M, Ribe EM, Nevado-Holgado A, Lovestone S, Sanz F, Furlong LI, Valverde O. Comorbidity between Alzheimer's disease and major depression: a behavioural and transcriptomic characterization study in mice. Alzheimers Res Ther 2021;13:73. [PMID: 33795014 DOI: 10.1186/s13195-021-00810-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Yang KC, Liu MN, Liou YJ, Hu LY, Yang BH, Chou YH. Interleukin-1 family and serotonin transporter in first-episode, drug-naive major depressive disorder: A pilot study. J Psychiatr Res 2021;135:174-80. [PMID: 33493946 DOI: 10.1016/j.jpsychires.2021.01.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
9 Yamazaki K, Yoshino Y, Kawabe K, Ibuki T, Ochi S, Mori Y, Ozaki Y, Numata S, Iga JI, Ohmori T, Ueno SI. ABCA7 Gene Expression and Genetic Association Study in Schizophrenia. Neuropsychiatr Dis Treat 2020;16:441-6. [PMID: 32103964 DOI: 10.2147/NDT.S238471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Cook IA, Congdon E, Krantz DE, Hunter AM, Coppola G, Hamilton SP, Leuchter AF. Time Course of Changes in Peripheral Blood Gene Expression During Medication Treatment for Major Depressive Disorder. Front Genet 2019;10:870. [PMID: 31620172 DOI: 10.3389/fgene.2019.00870] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sao T, Yoshino Y, Yamazaki K, Ozaki Y, Mori Y, Ochi S, Yoshida T, Mori T, Iga JI, Ueno SI. TREM1 mRNA Expression in Leukocytes and Cognitive Function in Japanese Patients with Alzheimer's Disease. J Alzheimers Dis 2018;64:1275-84. [PMID: 30010135 DOI: 10.3233/JAD-180418] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
12 Pan Z, Grovu RC, Mcintyre RS. Translational Medicine Strategies in Drug Development for Mood Disorders. Translational Medicine in CNS Drug Development 2019. [DOI: 10.1016/b978-0-12-803161-2.00023-0] [Reference Citation Analysis]
13 Yoshino Y, Funahashi Y, Nakata S, Ozaki Y, Yamazaki K, Yoshida T, Mori T, Mori Y, Ochi S, Iga J, Ueno S. Ghrelin cascade changes in the peripheral blood of Japanese patients with Alzheimer's disease. Journal of Psychiatric Research 2018;107:79-85. [DOI: 10.1016/j.jpsychires.2018.10.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
14 Nollet M, Hicks H, Mccarthy AP, Wu H, Möller-levet CS, Laing EE, Malki K, Lawless N, Wafford KA, Dijk D, Winsky-sommerer R. REM sleep: unique associations with behavior, corticosterone regulation and apoptotic pathways in chronic stress in mice.. [DOI: 10.1101/460600] [Reference Citation Analysis]
15 Mise A, Yoshino Y, Yamazaki K, Ozaki Y, Sao T, Yoshida T, Mori T, Mori Y, Ochi S, Iga JI, Ueno SI. TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects. J Alzheimers Dis 2017;60:1107-17. [PMID: 28984592 DOI: 10.3233/JAD-170361] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
16 Yamazaki K, Yoshino Y, Mori T, Yoshida T, Ozaki Y, Sao T, Mori Y, Ochi S, Iga JI, Ueno SI. Gene Expression and Methylation Analysis of ABCA7 in Patients with Alzheimer's Disease. J Alzheimers Dis 2017;57:171-81. [PMID: 28222527 DOI: 10.3233/JAD-161195] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
17 Yoshino Y, Mori T, Yoshida T, Yamazaki K, Ozaki Y, Sao T, Funahashi Y, Iga JI, Ueno SI. Elevated mRNA Expression and Low Methylation of SNCA in Japanese Alzheimer's Disease Subjects. J Alzheimers Dis 2016;54:1349-57. [PMID: 27567856 DOI: 10.3233/JAD-160430] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
18 Menezes IC, von Werne Baes C, Lacchini R, Juruena MF. Genetic biomarkers for differential diagnosis of major depressive disorder and bipolar disorder: A systematic and critical review. Behav Brain Res 2019;357-358:29-38. [PMID: 29331712 DOI: 10.1016/j.bbr.2018.01.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
19 Sao T, Yoshino Y, Yamazaki K, Ozaki Y, Mori Y, Ochi S, Yoshida T, Mori T, Iga J, Ueno S. MEF2C mRNA expression and cognitive function in Japanese patients with Alzheimer's disease: MEF2C expression in Alzheimer's disease. Psychiatry Clin Neurosci 2018;72:160-7. [DOI: 10.1111/pcn.12618] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
20 Muñoz-Cobo I, Belloch FB, Díaz-Perdigón T, Puerta E, Tordera RM. SIRT2 inhibition reverses anhedonia in the VGLUT1+/- depression model. Behav Brain Res 2017;335:128-31. [PMID: 28778545 DOI: 10.1016/j.bbr.2017.07.045] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
21 Yoshino Y, Yamazaki K, Ozaki Y, Sao T, Yoshida T, Mori T, Mori Y, Ochi S, Iga J, Ueno S. INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer’s Disease Subjects. JAD 2017;58:687-94. [DOI: 10.3233/jad-161211] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
22 Ozaki Y, Yoshino Y, Yamazaki K, Sao T, Mori Y, Ochi S, Yoshida T, Mori T, Iga JI, Ueno SI. DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease. J Psychiatr Res. 2017;92:74-80. [PMID: 28412600 DOI: 10.1016/j.jpsychires.2017.04.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 10.4] [Reference Citation Analysis]
23 Watanabe SY, Numata S, Iga JI, Kinoshita M, Umehara H, Ishii K, Ohmori T. Gene expression-based biological test for major depressive disorder: an advanced study. Neuropsychiatr Dis Treat 2017;13:535-41. [PMID: 28260899 DOI: 10.2147/NDT.S120038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
24 Funahashi Y, Yoshino Y, Yamazaki K, Mori Y, Mori T, Ozaki Y, Sao T, Ochi S, Iga J, Ueno S. DNA methylation changes at SNCA intron 1 in patients with dementia with Lewy bodies: DNA methylation at SNCA intron 1 in DLB. Psychiatry Clin Neurosci 2017;71:28-35. [DOI: 10.1111/pcn.12462] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 6.8] [Reference Citation Analysis]
25 Cui X, Niu W, Kong L, He M, Jiang K, Chen S, Zhong A, Li W, Lu J, Zhang L. hsa_circRNA_103636: potential novel diagnostic and therapeutic biomarker in Major depressive disorder. Biomarkers in Medicine 2016;10:943-52. [DOI: 10.2217/bmm-2016-0130] [Cited by in Crossref: 85] [Cited by in F6Publishing: 92] [Article Influence: 14.2] [Reference Citation Analysis]
26 Mori Y, Yoshino Y, Ochi S, Yamazaki K, Kawabe K, Abe M, Kitano T, Ozaki Y, Yoshida T, Numata S, Mori T, Iga J, Kuroda N, Ohmori T, Ueno S. TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer's Disease and Schizophrenia. PLoS One 2015;10:e0136835. [PMID: 26332043 DOI: 10.1371/journal.pone.0136835] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]